To meet the growing demand for alternatives to spinal fusion, Kevin Pauza, MD, certified 14 spine specialists to perform the Discseel procedure at Weill Cornell Brain and Spine Center in New York City.
Biologics
The global platelet rich plasma market is projected to increase from 2018 through 2026 at a 13.3 percent compound annual growth rate, according to a Credence Research report.
Pete O'Heeron is the founder and CEO of SpinalCyte.
Aziyo Biologics will exclusively distribute its bone repair product ViBone through RTI Surgical in the U.S.
Asterias Biotherapeutics provided an update from its ongoing phase 1/2a clinical trial of a stem cell treatment for severe spinal cord injury.
Advertisement
Ortho Regenerative Technologies earned extensions of expiry dates on certain warrants.
Johnson City, Tenn.-based Appalachian Orthopedics now offers cartilage restoration procedures.
Tom Cycyota is the president and CEO of AlloSource.
BioRestorative Therapies develops stem cell treatments for chronic back pain caused by disc degeneration.
Cerapedics began its investigational device exemption clinical trial for its P-15L Peptide Enhanced Bone Graft.